Androgen R/NR3C4, p Ser210 Antibody (156C135.2), Alexa Fluor™ 532, Novus Biologicals™

Androgen R/NR3C4

Monoclonal

Alexa Fluor 532

50 mM sodium borate with 0.05% sodium azide

AR

This antibody was developed against a synthetic peptide corresponding to amino acids 207-221 (GRAREAS*GAPTSSKD) of human androgen receptor, containing the serine 213 phosphorylation site: GenBank Accession No. A39248. Note: S* refers to phosphorylated serine in the peptide sequence.

0.1 mL

Primary

In IGF-1 stimulated LNCaP cells (passage number 38), a ∼110 kDa band was observed. Please see Lin et al. 2003 for additional details. The serine phosphorylation site recognized by this antibody has been alternatively referred to Ser213 (Lee and Chang, 2003) and Ser210 (Lin et al, 2003). Variations in denotation can arise from how the sequence is counted in various GenBank accession numbers. The site is denoted as Ser213 in GenBank Accession No. A39248, which was used to design the immunogen.

Store at 4°C in the dark.

Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)

156C135.2

Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin

AIS, androgen receptor, DHTRTFM, Dihydrotestosterone receptorHYSP1, HUMARA, NR3C4KD, Nuclear receptor subfamily 3 group C member 4, SMAX1SBMA, spinal and bulbar muscular atrophy

Mouse

Protein G purified

Breast Cancer, Cancer, Cellular Markers, Phospho Specific

367.0

Human, Mouse, Rat, Canine, Primate

IgG1 κ